[HTML][HTML] Staging of non-small cell lung cancer (NSCLC): a review

S Tsim, CA O'dowd, R Milroy, S Davidson - Respiratory medicine, 2010 - Elsevier
Lung cancer remains the most common cause of cancer-related mortality in Scotland,
accounting for 28.9% of all cancer deaths in 2007.1 Current guidelines recommend …

Effects of the pH dependence of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel …

JA Plumb, R Milroy, SB Kaye - Cancer research, 1989 - AACR
Abstract The tetrazolium dye, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT), is reduced by live but not dead cells, and this reaction is used as the end point in a …

The deterioration of hearing with age: Frequency selectivity, the critical ratio, the audiogram, and speech threshold

…, I Nimmo‐Smith, DL Weber, R Milroy - The Journal of the …, 1982 - pubs.aip.org
The frequency selectivity of the auditory system was measured by masking a sinusoidal
signal (0.5, 2.0, or 4.0 kHz) or a filtered‐speech signal with a wideband noise having a …

Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial

…, RJ Stephens, NH Gower, R Milroy… - European journal of …, 2004 - academic.oup.com
Objectives: The non-small cell lung cancer (NSCLC) meta-analysis suggested a survival
benefit for cisplatin-based chemotherapy when given in addition to surgery, radical …

[HTML][HTML] The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer

…, LM Forrest, DJF Brown, CS McArdle, R Milroy - British journal of …, 2002 - nature.com
The relationship between the magnitude of systemic inflammatory response and the
nutritional/functional parameters in patients with inoperable non-small cell lung cancer were …

Quality of life in lung cancer patients: as an important prognostic factor

A Montazeri, R Milroy, D Hole, J McEwen, CR Gillis - Lung cancer, 2001 - Elsevier
Given that lung cancer is one of the common cancers world-wide, the implications of
focusing on quality of life as well as survival require to be understood. We have carried out a …

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer–a randomized trial with quality of life as the primary outcome

…, N Thatcher, B Cottier, M Nicholson, R Milroy… - British journal of …, 2000 - nature.com
Three hundred patients with symptomatic, locally advanced or metastatic NSCLC not
requiring immediate radiotherapy were enrolled into this randomized multicentre trial …

Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life

…, J Brown, DJ Fairlamb, NH Gower, L Maslove, R Milroy… - Thorax, 2004 - thorax.bmj.com
Background: In 1995 a meta-analysis of randomised trials investigating the value of adding
chemotherapy to primary treatment for non-small cell lung cancer (NSCLC) suggested a …

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

…, DC McMillan, A Crilly, CS McArdle, R Milroy - British journal of …, 1996 - nature.com
Markers of the inflammatory response, interleukin 6, C-reactive protein, albumin and full
blood count, were measured in non-small-cell lung cancer (NSCLC) patients (n= 21) with …

The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer

DJF Brown, DC McMillan, R Milroy - Cancer, 2005 - Wiley Online Library
BACKGROUND Functional disability is reported frequently in fatigued cancer patients, but
little is known about the correlation between fatigue and objective physical function. In …